Seòmar agus comataidhean

This information is not held centrally. Public Health Scotland published a Gastrointestinal and Zoonoses report on 7 February 2023 which provides figures and trends of Lyme Disease. The report can be found at Gastrointestinal and Zoonoses - Biennial report 2020 to 2021 - Gastrointestinal and Zoonoses - Publications - Public Health Scotland .

If you have an enquiry relating to this publication, please email phs.giz@phs.scot.

Auditory Verbal UK is a suitable therapeutic intervention for some young people, and it remains an option that can be pursued by local health boards.

The provision of services including suitable therapeutic intervention remains a matter for local authorities and health boards.

We are supporting NHS Greater Glasgow and Clyde to improve existing service capacity in both the adult and young people’s services and recruit to their multidisciplinary teams.

All gender identity clinics in Scotland are, however, working hard to reduce waiting times and provide support for those on their waiting lists, including through new clinical delivery approaches based on local need. The Scottish Government is working closely with NHS Boards and plans further investment in 2024-25, to help improve services and reduce gender identity clinic waiting times.

The M8 Woodside Viaduct is a vital element of Scotland’s motorway network, carrying approximately 150,000 vehicles daily. Installation of the temporary propping system, required to enable permanent repairs, will continue through the 2024-25 financial year. It is anticipated that the project will be Transport Scotland’s largest capital-funded transport project in Glasgow during this period.

Other significant Government-led transport projects in Glasgow in 2024-25 include the East Kilbride rail enhancement project (£54.1m for 2024-25), active travel infrastructure projects and investing in Glasgow’s City Region Deal. This response does not consider projects by other authorities e.g. Glasgow City Council.

Within the Scottish Government, funding for Health and Care Research comes under the policy remit of the Chief Scientist Office (CSO)

(A) The following table provides the amount in cash terms of CSO cancer research funding per year from 2011-12

Column 1 - NHS Research Scotland (NRS) - includes funding for the NRS Cancer Research Network; the CSO component of funding for the Experimental Cancer Medicine Centres in Edinburgh and Glasgow (co-funded 50:50 with Cancer Research UK); NRS Career Research Fellowships in cancer

Column 2 - Direct Funding - includes cancer projects funded through the CSO grant funding committees; Academic Fellowships in cancer funded through the CSO capacity building programmes; the CSO component of collaborative research project and fellowship funding with cancer research charities

Column 3 - total CSO cancer research funding by year

To note - for multi-year projects and fellowships, the funding figure is allocated to the year corresponding to the start date (in the case of cancer charity collaborations the funding is allocated to the year of the collaboration agreement)

The Scottish Government provides baseline funding to NHS boards. It is for each NHS Board to determine how best to utilise the funding and resources provided by the Scottish Government to meet the needs and priorities of their local populations, and to ensure that the care they provide is safe, effective and person-centred.

I refer the member to the answer to question S6W-26312 on 8 April 2024. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

I refer the member to the answer to question S6W-26312 on 8 April 2024. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

Our priority is to ensure those people referred for suspected cancer or via screening programmes receive the appropriate diagnosis and treatment safely, based on their clinical urgency. To specifically support scope-based diagnostics, we have published a £70m Endoscopy and Urology Diagnostic Recovery and Renewal Plan, including provision of additional endoscopy training places via the NHS Academy to future-proof the workforce and provide additional diagnostic capacity to reduce waiting times.

The Digital Prescribing and Dispensing Pathways (DPDP) programme, is scheduled to replace the current paper prescription in Scotland with a digital approach by the end of this parliamentary term.

The business case which sets out the proposal for the next phase, and associated funding, for the programme are currently under consideration.